NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/23/2026
Back to search
Official data from USPTO
OCUBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/23/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 44
Filing date
03/26/2024
Registration date
10/21/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2025
First use in commerce
03/01/2025
Drawing code
4
Owner type
16
Owner location
Miami, FL, US
Examiner
SCHRADER, BRITTANY A
Current location
Historical data usage
Holders and representatives
Holders
Ocubio, LLC
Representatives
Katherine Koenig Koenig IP Works, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Eye drops; ocular pharmaceuticals; pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; pharmaceutical preparations for ocular or intraocular surgery
Class 44
Pharmaceutical compounding services ; medical diagnostic services; blood analysis services for diagnostic purposes provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; blood serum analysis services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing services of blood serums; medical testing services of tear fluid
Publications
History of USPTO decisions and trademark events.
25 publications found
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/19/2026
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/21/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
03/31/2026
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
03/12/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2026
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/01/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/01/2025
IUAF
USE AMENDMENT FILED
05/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/03/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/19/2024
PUBO
PUBLISHED FOR OPPOSITION
11/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2024
DOCK
ASSIGNED TO EXAMINER
10/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2024
NWAP
NEW APPLICATION ENTERED
03/26/2024
Continuous trademark protection
Get notified about every new filing that threatens OCUBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.